Investing Profile

Brian Keil

InvestorVC
Managing Partner at Alumni Ventures Group
avgfunds.comNew York, New York
Photo of Brian Keil, Managing Partner at Alumni Ventures
Your Intro Paths to Brian Keil

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Brian Keil on

cb
Current Investing Position
Alumni Ventures Managing Partner
Investment Range
$50K - $10.0M
Sweet Spot
$5.0M
Investments On Record
47
Current Fund Size
$539.4M

Brian Keil is on these Sector & Stage Rankings

Brian Keil's Investments On Record (34)

CompanyStageDateRound SizeTotal Raised
Enfabrica
Series CNov 2024$120M
Series BSep 2023$130M
$240M
Co-investors: Gavin Baker (Atreides Management)
Q-CTRL
Series BOct 2024$59M
Convertible NoteNov 2022
$130M
Co-investors: Ben Yu (Sierra Ventures), James Hardiman (DCVC (Data Collective)), Steven Ji (Sequoia Capital China), Robert Keith (Salesforce Ventures), Damien Petty (Morpheus Ventures), Phil Morle (Main Sequence Ventures), Lewis Pinault (Airbus Ventures), Chris Moran (Lockheed Martin Ventures)
MD Ally
Series AAug 2024$14M
$18M
Co-investors: Hemant Taneja (General Catalyst), Tuoyo Louis (Seae Ventures), Brett Topche
Inventive
SeedJun 2024$7M
$7M
Co-investors: Chris Zeoli (Base10 (Base10 Partners) )
Atom Computing
Series UnknownJun 2024$10M
$90M
Co-investors: Kyle Lui (DCM), Christian Edler (BITKRAFT Ventures), Dror Berman (Innovation Endeavors), Ethan Batraski (Venrock), Gaetano Crupi (Prime Movers Lab), Fernando Pontaza (Invariantes Fund), Curtis McKee (Third Point Ventures), Ian Rountree (Cantos Ventures)
HerculesAI
Series BMay 2024$26M
$38M
Co-investors: Ullas Naik (Streamlined Ventures), Peter Bordes (Trajectory Ventures), Florian Leibert (468 Capital)
ARRIS
Series UnknownApr 2024$34M
Series CNov 2021$89M
Series BApr 2020$49M
Series UnknownFeb 2020$6M
$190M
Co-investors: Jeff Immelt (New Enterprise Associates (NEA)), Greg Papadopoulos (New Enterprise Associates (NEA)), David Shapiro (Alumni Ventures ), David Beazley (Alumni Ventures ), Anton Simunovic (Alumni Ventures ), Laura Rippy (Alumni Ventures ), Tom Meyer (Alumni Ventures ), Matthew Caspari (Alumni Ventures ), Andre De Baubigny (Modern Venture Partners)
Iambic Therapeutics
Series BApr 2024$50M
$200M
Co-investors: R. Jacob Vogelstein (Catalio Capital), Kurt von Emster (Abingworth), Naren Gupta (Nexus Venture Partners), Ayman AlAbdallah